14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

<div>Development of 14-CpG-based signatures for HCC patients in the development cohort (<i>N</i> = 263). (a) The heat map of the methylation levels of the 14 CpGs in high-risk and low-risk patients; (b) distribution of overall status of high-risk and low-risk patients; (c) Kaplan–Meier analysis of overall survival time of high-risk and low-risk patients.</div>

BioMed Research International

fig3

Figure 3

Figure 3: 14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients 